Effect of sirolimus on coagulopathy of slow-flow vascular malformations

A xenograft model for venous malformation

(2018) Jillian Goines et al.   ANGIOGENESIS

PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations

(2018) Laura di Blasio et al.   Cell Death & Disease

Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study

(2018) Jennifer Hammer et al.   Orphanet Journal of Rare Diseases

Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study

(2017) Yi Ji et al.   INTERNATIONAL JOURNAL OF CANCER

Localised intravascular coagulation complicating venous malformations in children: Associations and therapeutic options

(2017) Kevin Y Zhuo et al.   JOURNAL OF PAEDIATRICS AND CHILD HEALTH

Venous Thromboembolism in Pediatric Vascular Anomalies

(2017) Taizo A. Nakano et al.   Frontiers in Pediatrics

Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies

(2016) D. M. Adams et al.   PEDIATRICS

Somatic PIK3CA mutations as a driver of sporadic venous malformations

(2016) Pau Castel et al.   Science Translational Medicine

Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects

(2015) Elisa Boscolo et al.   JOURNAL OF CLINICAL INVESTIGATION

Sirolimus for the treatment of complicated vascular anomalies in children

(2011) Adrienne M. Hammill et al.   PEDIATRIC BLOOD & CANCER

Venous malformation: update on aetiopathogenesis, diagnosis and management

(2010) A Dompmartin et al.   PHLEBOLOGY

Elevated D-dimer Level in the Differential Diagnosis of Venous Malformations

(2009) Anne Dompmartin et al.   ARCHIVES OF DERMATOLOGY

Association of Localized Intravascular Coagulopathy With Venous Malformations

(2008) Anne Dompmartin et al.   ARCHIVES OF DERMATOLOGY